MENU
+Compare
CORT
Stock ticker: NASDAQ
AS OF
Feb 21, 04:59 PM (EDT)
Price
$63.48
Change
-$1.61 (-2.47%)
Capitalization
6.65B

CORT Corcept Therapeutics Forecast, Technical & Fundamental Analysis

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CORT with price predictions
Feb 20, 2025

CORT in +8.08% Uptrend, rising for three consecutive days on February 13, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CORT advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

CORT moved above its 50-day moving average on January 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CORT crossed bullishly above the 50-day moving average on January 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 262 cases where CORT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CORT moved out of overbought territory on February 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where CORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CORT as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CORT turned negative on February 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CORT broke above its upper Bollinger Band on January 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.672) is normal, around the industry mean (12.644). P/E Ratio (51.659) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). CORT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (11.534) is also within normal values, averaging (254.739).

View a ticker or compare two or three
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CORT is expected to report earnings to fall 8.07% to 37 cents per share on February 26

Corcept Therapeutics CORT Stock Earnings Reports
Q4'24
Est.
$0.38
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.01
The last earnings report on October 30 showed earnings per share of 40 cents, beating the estimate of 28 cents. With 1.21M shares outstanding, the current market capitalization sits at 6.65B.
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDG75.090.41
+0.55%
iShares MSCI Global Sust Dev Goals ETF
BBIN61.830.30
+0.49%
JPMorgan BetaBuilders Intl Eq ETF
HCOM15.70N/A
N/A
Hartford Schroders Commodity Strtgy ETF
MJUS0.76N/A
N/A
Amplify US Alternative Harvest ETF
DUSA45.83-0.23
-0.50%
Davis Select US Equity ETF

CORT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with DNLI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-11.48%
DNLI - CORT
44%
Loosely correlated
-2.88%
AGIO - CORT
44%
Loosely correlated
-0.79%
TENX - CORT
41%
Loosely correlated
-8.51%
OXBOF - CORT
40%
Loosely correlated
N/A
MDXG - CORT
39%
Loosely correlated
-2.61%
More